Ra Medical Systems Inc. (RMED)
AMEX: RMED
· Real-Time Price · USD
0.59
0.05 (9.26%)
At close: Aug 17, 2023, 10:00 PM
Ra Medical Systems Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 425K | 421K | 431K | 420K | 341K | 202K | 104K | 28K | 19K | 24K | 1.02M | 2.13M | 3.35M | 4.25M | 4.15M |
Cost of Revenue | 43K | 44K | 52K | 52K | 197K | 185K | 237K | 322K | 508K | 754K | 2.18M | 3.45M | 4.42M | 5.59M | 5.27M |
Gross Profit | 382K | 377K | 379K | 368K | 144K | 17K | -133K | -294K | -489K | -730K | -1.15M | -1.32M | -1.07M | -1.34M | -1.12M |
Operating Income | -57.05M | -56.21M | -14.6M | 33.95M | 28.45M | 26.4M | 24.23M | -26.96M | -27.01M | -29.62M | -28.4M | -30.09M | -32.2M | -32.58M | -35.45M |
Interest Income | -167K | -98K | 215K | 277K | 275K | 188K | 69K | n/a | n/a | n/a | 1K | 2K | 3K | 7K | 16K |
Pretax Income | 43.29M | 46.13M | -11.84M | -74.12M | -78.06M | -80.89M | -87.77M | -26.86M | -26.99M | -29.6M | -26.41M | -28.15M | -30.3M | -30.7M | -35.57M |
Net Income | 36.52M | 38.63M | -11.84M | -74.92M | -78.86M | -81.68M | -88.55M | -26.84M | -26.97M | -26.53M | -23.33M | -25.07M | -27.23M | -30.71M | -35.58M |
Selling & General & Admin | 12.12M | 11.38M | 9.76M | 17.11M | 22.35M | 23.12M | 24.18M | 16.25M | 12.48M | 13.18M | 14.44M | 16.26M | 18.93M | 19.65M | 23.8M |
Research & Development | 461K | 470K | 390K | 567K | 640K | 1.25M | 3.52M | 6.39M | 9.97M | 12.19M | 12.81M | 12.51M | 12.2M | 11.59M | 10.53M |
Other Expenses | 108K | n/a | 4.83M | 4.85M | 4.91M | 4.93M | 106K | 99K | 21K | 17K | 5K | -3K | -37K | -63K | -63K |
Operating Expenses | 12.69M | 11.85M | 14.98M | 22.51M | 27.82M | 29.21M | 27.7M | 22.64M | 22.45M | 25.36M | 27.25M | 28.76M | 31.13M | 31.24M | 34.33M |
Interest Expense | -172K | -123K | -32K | n/a | 17K | 17K | 17K | 17K | n/a | n/a | 31K | 83K | 137K | 151K | 135K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.74M | 11.9M | 15.03M | 22.56M | 27.86M | 29.23M | 27.77M | 22.8M | 22.96M | 26.12M | 29.43M | 32.22M | 35.55M | 36.83M | 39.6M |
Income Tax Expense | 1.62M | 2.34M | n/a | 800K | 803K | 783K | 783K | -17K | -16K | -3.08M | -3.04M | -3.04M | -3.04M | 39K | 18K |
Shares Outstanding (Basic) | 11.28M | 3.26M | 2.05M | 7.57M | 6.81M | 5.36M | 2.73M | 2.16M | 1.09M | 643.24K | 400.75K | 134K | 128K | 81.78K | 58.34K |
Shares Outstanding (Diluted) | 11.28M | 3.26M | 2.05M | 7.57M | 6.81M | 5.36M | 2.73M | 2.16M | 1.09M | 643.24K | 400.75K | 134K | 128K | 81.78K | 58.34K |
EPS (Basic) | 10.60 | 10.68 | -8.15 | -30.79 | -29 | -33.06 | -45.9 | -34.96 | -93.02 | -122.26 | -173.31 | -283.63 | -402.17 | -531.64 | -1K |
EPS (Diluted) | 10.60 | 10.68 | -8.15 | -30.79 | -29 | -33.06 | -45.9 | -34.96 | -93.02 | -122.26 | -173.31 | -283.63 | -402.17 | -531.64 | -1K |
EBITDA | 40.49M | 41.32M | -14.6M | 35.39M | 30.12M | 29.23M | 34.25M | -18.2M | -18.48M | -21.88M | -27.42M | -28.83M | -30.95M | -31.7M | -34.35M |
EBIT | n/a | n/a | n/a | 45.69M | 37.63M | 32.85M | 32.85M | -18.34M | -10.29M | -12.9M | -18.11M | -19.8M | -30.18M | -30.55M | -35.44M |
Depreciation & Amortization | -1.53M | -1.57M | 82.5K | 1.53M | 1.76M | 2.96M | 2.97M | 1.71M | 1.79M | 1.01M | 1.3M | 1.56M | 1.77M | 2.03M | 2.24M |